Christopher Kobylecki

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Frontotemporal dementia with right temporal predominance: a clinical comparison with left-predominant FTD.

Frontotemporal dementia with right temporal predominance: a clinical comparison with left-predominant FTD.

Journal: Journal of neurology

Published: May 01, 2026

Identification of common variants influencing risk of the three-repeat tauopathy Pick's disease: a genome wide association study.

Identification of common variants influencing risk of the three-repeat tauopathy Pick's disease: a genome wide association study.

Journal: medRxiv : the preprint server for health sciences

Published: January 02, 2026

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.

Journal: Brain : a journal of neurology

Published: December 15, 2025

Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.

Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 24, 2025

Bilateral facial palsy due to Melkersson-Rosenthal syndrome.

Bilateral facial palsy due to Melkersson-Rosenthal syndrome.

Journal: Practical neurology

Published: November 18, 2025

Parkinson's disease: the follow-up consultation.

Parkinson's disease: the follow-up consultation.

Journal: Practical neurology

Published: October 15, 2025

Clinical prognostic indicators in multiple system atrophy.

Clinical prognostic indicators in multiple system atrophy.

Journal: Brain : a journal of neurology

Published: September 09, 2025

Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.

Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.

Journal: BMJ open

Published: July 29, 2025

Speech Treatment for People with Cerebellar Multiple System Atrophy (MSA-C): A Pilot Randomised Controlled Trial of Two Approaches.

Speech Treatment for People with Cerebellar Multiple System Atrophy (MSA-C): A Pilot Randomised Controlled Trial of Two Approaches.

Journal: Cerebellum (London, England)

Published: April 16, 2025

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.

Journal: Annals of neurology

Published: March 25, 2025

No one size fits all approach with apomorphine initiation.

No one size fits all approach with apomorphine initiation.

Journal: Parkinsonism & related disorders

Published: December 30, 2024

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.

Journal: The Lancet. Neurology

Published: December 10, 2024

Showing 1-12 of 101

Last Updated: 09/26/2026